ライフサイエンスコーパス: interval

1 T1, residing indeed in the shared autozygous interval.

2 marily by ePAL, age-at-sampling and the time interval.

3 as 0.0141 mSv/MBq when using a 3.5-h voiding interval.

4 It formed during the 900-500-Ma interval.

5 to initiate a given action at the end of an interval.

6 low error and good coverage of our credible intervals.

7 or and influences the perception of temporal intervals.

8 orting odds ratios (ROR) with 95% confidence intervals.

9 of differential odor conditioning with rest intervals.

10 aintained similar intervals, and 3 decreased intervals.

11 identified TBI across all acute and chronic intervals.

12 by estimating incubation periods and serial intervals.

13 d to estimate odds ratios and 95% confidence intervals.

14 vs 35.5%, P < 0.001; OR 0.20, 95% confidence interval 0.12-0.33).

15 at 4.5 years (beta = -0.095, 95% confidence interval = -0.184 to -0.005), with a standardized beta c

16 etection (hazard ratio, 0.40; 95% confidence interval, 0.20-0.80).

17 nchiectasis (difference, 0.9; 95% confidence interval, 0.3-1.6; P = 0.003) and Aspergillus with trapp

18 m donors >=80 years was 0.54 (95% confidence interval, 0.38-0.77; P < 0.0001).

19 r median odds ratios were 0.61 (95% credible interval, 0.41-0.90) and 0.68 (95% credible interval, 0.

20 interval, 0.41-0.90) and 0.68 (95% credible interval, 0.47-1.01) for 28-day and 90-day mortality, re

21 s (adjusted odds ratio, 0.73; 95% confidence interval, 0.57-0.93).

22 s (adjusted odds ratio, 0.87; 95% confidence interval, 0.79-0.94).

23 n [26%]; relative risk, 1.03; 95% confidence interval, 0.81 to 1.32; P = 0.80).

24 ndard care (odds ratio, 2.07; 95% confidence interval, 0.98-4.40; P = 0.058).

25 e lung volume of exhaled air (95% confidence interval, -0.17 to -0.07; P = 6.62 x 10(-8)) with each a

26 etween proportions was 0.87% (95% confidence interval, -0.84% to 2.59%).

27 death from MI increased 34% (95% confidence interval: 0%, 80%) on days with heavy snowfall (>=5 cm).

28 70 mg/dl (hazard ratio: 0.61; 95% confidence interval: 0.40 to 0.91; p = 0.016), whereas CABG was ass

29 adjusted hazard ratio: 0.61; 95% confidence interval: 0.53 to 0.71; p < 0.001).

30 der the curve (AUC) of 0.694 (95% Confidence Interval: 0.612-0.776) and classified correctly 62.4% of

31 e5 vs. 1 hazard ratio = 0.79, 95% confidence interval: 0.64, 0.98, and BH-adjusted Ptrend = 0.1).

32 adjusted hazard ratio: 0.77; 95% confidence interval: 0.68 to 0.88; p < 0.001) and all-cause-mortali

33 e5 vs. 1 hazard ratio = 0.81, 95% confidence interval: 0.71, 0.92, and BH-adjusted Ptrend = 0.001; an

34 0 in the contemporary cohort (95% confidence interval: 0.723-0.758; sensitivity 81%, specificity 54%)

35 ate of PD (rate ratio = 0.83, 95% confidence interval: 0.75, 0.91) compared with no use.

36 0.766 in the primary cohort (95% confidence interval: 0.750-0.782; sensitivity 75%, specificity 65%)

37 lization (hazard ratio: 0.86; 95% confidence interval: 0.81 to 0.92; p < 0.001), with no significant

38 characteristic curve of 0.89 (95% confidence interval: 0.82, 0.96) and an area under the precision-re

39 atio: 0.91 per -5 mm Hg PASP; 95% confidence interval: 0.86 to 0.96; p = 0.0009).

40 [4-year relative survival and 95% confidence interval: 0.87 (0.85-0.89), 0.87 (0.86-0.88), 0.89 (0.86

41 (adjusted hazard ratio, 1.4; 95% confidence interval: 0.9, 1.9; P = .17).

42 ecision-recall curve of 0.96 (95% confidence interval: 0.93, 0.99).

43 e 2 groups (odds ratio: 1.18; 95% confidence interval: 0.99 to 1.41; p = 0.26).

44 male (hazard ratio (HR) 1.59 (95% confidence interval 1.53-1.65)); greater age and deprivation (both

45 e group (mean difference 9.7, 95% confidence interval 1.7-17.7, P = 0.018), which approached but did

46 trapped air (difference, 3.2; 95% confidence interval, 1.0-5.4; P = 0.004).

47 ge infants (odds ratio, 1.15; 95% confidence interval, 1.06, 1.24); conversely, there was no increase

48 s (marginal relative risk and 95% confidence interval, 1.161.501.95).

49 12 months (hazard ratio, 1.77 [95% credible interval, 1.18-2.66], posterior probability: 82.2%) were

50 : P = 0.04; odds ratio, 25.4; 95% confidence interval, 1.2-143; SMARCE1: P = 0.001; odds ratio, 2047;

51 L) had an OR for VTE of 2.05 (95% confidence interval, 1.37-3.08) compared with those with GDF-15 in

52 r diabetes (rate ratio, 1.55; 95% confidence interval, 1.48-1.61).

53 2: P = 0.02; odds ratio, 8.9; 95% confidence interval, 1.5-30.6; MLH1: P = 0.04; odds ratio, 25.4; 95

54 ysfunction (hazard ratio, 2.28 [95% credible interval, 1.59-3.28], posterior probability, 100.0%) and

55 tion (adjusted odds ratio 4.0 95% confidence interval, 1.7-10.6).

56 years at enrollment to 1.13 (95% confidence interval: 1.02, 1.26) in those aged 70-89 years at enrol

57 standard deviation were 1.10 (95% confidence interval: 1.05, 1.16) and 1.15 (1.10, 1.19) for women an

58 (adjusted hazard ratio, 3.7; 95% confidence interval: 1.1, 12.6; P = .04), but not for further hepat

59 at BMI assessment, from 1.25 (95% confidence interval: 1.18, 1.33) in persons aged 30-49 years at enr

60 10-ms decrease in EMW: 1.37; 95% confidence interval: 1.27 to 1.48; p < 0.0001).

61 r stroke (hazard ratio: 1.34; 95% confidence interval: 1.28 to 1.40) and major amputation or peripher

62 (adjusted hazard ratio, 3.8; 95% confidence interval: 1.7, 9.5; P = .004).

63 baseline-adjusted difference [95% confidence interval] -1.91 minutes [-5.53 to 1.70], p = 0.316).

64 concentrations of 13.5 umol/L (95% credible interval 10.1-17.7) were associated with 1% mortality.

65 e LBT arm (odds ratio, 28.72; 95% confidence interval, 10.27-80.31).

66 adjusted relative risk, 0.30 [95% confidence interval, .12-.74]; P = .010).

67 ared to non-WASH arms, -0.07 [95% confidence interval, -.14 to -.02]), but had no statistically signi

68 uary through May 2020, 206,000 (95% credible interval, 178,100-231,000) more people died in these cou

69 ; percentage decrease, 26.5%; 95% confidence interval, 18.7-34.1) with no change in the case-fatality

70 ease in the recrudescence rate (95% credible interval: [18%, 62%]), and a 11% decrease of the viral g

71 0% long shifts was 15% lower (95% confidence interval 2% to 27%) than with all long shifts.

72 ain sharing (odds ratio 8.50; 95% confidence interval 2.2 - 33.4, P = 0.002).

73 was estimated at 3.1 (95% Bayesian credible interval = 2.4-5.5), with a higher median but overlappin

74 l, 3.3 to 5.1), and 2.9 points (95% credible interval, 2.2 to 3.7) higher with the invasive strategy

75 ed 30-day mortality (OR, 8.4 [95% confidence interval, 2.23-31.7]).

76 (adjusted hazard ratio, 7.4; 95% confidence interval: 2.7, 20.2; P < .001) and those with DACLD (adj

77 rval 38.5-75.5) vs 33 months (95% confidence interval 20.3-45.7), P = 0.03].

78 , RYGB patients had 28.4%TWL (95% confidence interval: 28.2, 28.5), SG 23.0%TWL (22.8, 23.2), and non

79 we observed a 35.3% decrease (95% confidence interval, 29.2%-41.8%]) and the median age shifted from

80 36 months that were 4.1 points (95% credible interval, 3.2 to 5.0), 4.2 points (95% credible interval

81 erval, 3.2 to 5.0), 4.2 points (95% credible interval, 3.3 to 5.1), and 2.9 points (95% credible inte

82 means difference: 3.9 mm(2); 95% confidence interval: 3.3 to 4.5; p < 0.0001).

83 d in a primary outcome (7.4%; 90% confidence interval: 3.4% to 15.9%).

84 Although less rate dependent than the QT intervals (36 +/- 19% of linear slopes), PQ intervals we

85 survival benefit [57 months (95% confidence interval 38.5-75.5) vs 33 months (95% confidence interva

86 for a score above 3 was 16.3 (95% confidence interval: 4.1 to 65.3; p < 0.0001).

87 rease of the viral growth rate (95% credible interval: [4%, 20%]).

88 nical outcomes (hazard ratio [95% confidence interval], 4.8 [2.6-9.0], P < 0.01) when compared to abs

89 ate that groundwater from the affected depth interval (40-50 m) was recharged >60 years ago.

90 Three-year OS was 55.5% (95% confidence interval, 40.8-68.0).

91 P = 0.001; odds ratio, 2047; 95% confidence interval, 52-4.5e15, respectively).

92 proaches was 26 of 34 (76.5%, 95% confidence interval = 58.8-89.3%) in <4 months, greater than histor

93 oses for 72% of the patients (95% confidence interval = 60-85%); chance-adjusted agreement was determ

94 omplicated falciparum malaria had shorter QT intervals (-61.77 milliseconds; 95% credible interval [C

95 ulative probability being 9% (95% confidence interval 7%-12%).

96 rization (hazard ratio: 8.13; 95% confidence interval: 7.96 to 8.29).

97 -95%) and specificity of 85% (95% confidence interval, 71%-93%).

98 e predictive value was 93.3% (95% confidence interval, 77.6%-99.2%) by histopathologic validation and

99 ected from a geocentric axial dipole for the interval 8 to 11 million years ago, but with very large

100 failure (hazard ratio, 11.40; 95% confidence interval, 8.38 to 15.50), followed by coronary heart dis

101 strated a sensitivity of 90% (95% confidence interval, 81%-95%) and specificity of 85% (95% confidenc

102 d (adjusted odds ratio, 1.44; 95% confidence interval, .81-2.56).

103 outcome and 98 patients (90%; 95% confidence interval, 83 to 95) had a favorable outcome.

104 admission (odds ratio, 0.97; 95% confidence interval, .85-1.12; P = .71).

105 hologic validation and 96.2% (95% confidence interval, 86.3%-99.7%) by the combination of histology a

106 dence rate ratio [aIRR] 1.12, 95% confidence interval [95% CI] 1.11-1.13, p < 0.001, per deprivation

107 CKD (hazard ratio [HR], 1.51; 95% confidence interval [95% CI], 1.08 to 2.10), which was attenuated a

108 tients; odds ratio [OR], 2.7; 95% confidence interval [95% CI], 1.6 to 3.8; P=0.02) as well as higher

109 increase in the odds of AKI (95% confidence interval [95% CI], 3.64 to 22.93) and a 22.86-fold incre

110 The PQ interval also responded to the heart rate changes with a

111 is mortality rates were determined in 3-year intervals among prevalent dialysis patients in the Unite

112 riants near TBX3 that are associated with PR interval and QRS duration, suggesting that subtle change

113 rated pooled reference samples at predefined intervals and enables a single-step batch correction and

114 until antibiotics with patients with shorter intervals and reporting a single blended (and thus infla

115 tests were at two-time sets; 24-h and 21-day intervals and results showed a good correlation between

116 larly distributed along the filament at 4-nm intervals and we can determine the domains that associat

117 given five times, administered at one 4 week interval, and every 8 weeks thereafter) or placebo.

118 reductions, including parity, interpregnancy interval, and maternal height.

119 no further injections, 3 maintained similar intervals, and 3 decreased intervals.

120 ET can be used to predict contacts, distance intervals, and real-valued distances.

121 EMW outperformed heart rate-corrected QT interval as a predictor of symptomatic status.

122 ables (subhazard ratio [SHR] [95% confidence interval]) associated with developing clinical outcomes

123 s the link between movement coordination and interval-based timing by addressing how motor training d

124 cal experimental factors, including the time interval between IN administration and FUS sonication (T

125 Depending upon the time-interval between injections, increasing the number of in

126 to maternal microbiome (ie no labour, short interval between membrane rupture and delivery) showed n

127 For the subgroup, the mean interval between the first and last ferumoxytol administ

128 rve produced a clear SAI (P < 0.05) when the interval between trigeminal stimulation and transcranial

129 percentile within each of 10 age groups (5-y intervals between 30 and 74 y as well as >=75 y).

130 ncluding recall rates, cancer detection, and interval cancers.

131 ean IOP change was -0.5 mmHg (95% confidence interval CI, -0.6 to -0.3 mmHg) at 12 months and -0.4 mm

132 idence rate ratio (IRR) 1.17; 95% confidence interval (CI) 0.76-1.63; P = 0.467], but there was stron

133 e risk (RR) of FTR was 0.84, (95% confidence interval (CI) 0.78-0.90) after implementation of CCRT, w

134 gastrectomy (SG; 64.5%; RR 0.92, confidence interval (CI) 0.86-0.99) and adjustable gastric band (AG

135 with any "high in" (from 51% [95% confidence interval (CI) 49-52] to 44% [95% CI 42-45]), mostly in f

136 adjustments, WLZ-O had 89 g (95% confidence interval (CI) 5; 172) lower FFM compared to MUAC-O.

137 We examine the bias, confidence interval (CI) coverage, and bias-variance tradeoff of qu

138 ate the hazard ratio (HR) and 95% confidence interval (CI) for the association of CRC diagnosed more

139 al validation cohort of 0.76 [95% confidence interval (CI), 0.72 to 0.79] for AKI, 0.79 (95% CI, 0.74

140 under the curve (AUC), 0.93; 95% confidence interval (CI), 0.87-1.00].

141 co use (odds ratio (OR), 2.0; 95% confidence interval (CI), 1.2-3.4, P = 0.009), coronary artery dise

142 37 of 208 women [FNR, 17.8%; 95% confidence interval (CI), 12.8-23.7%].

143 n mild glaucoma (mean, 42.2% [95% confidence interval (CI), 41.2%-43.2%] and 46.5% [95% CI, 44.8%-48.

144 stimate hazard ratio (HR) and 95% confidence interval (CI).

145 [absolute difference: - 0.62; 95% confidence interval (CI): - 0.12, - 0.01; p = 0.04; absolute differ

146 ase of MI 6 h later by 3.27% [95% confidence interval (CI): 0.27, 6.37], 5.71% (95% CI: 1.79, 9.77),

147 1, 2, and 3 doses were 0.53 (95% confidence interval (CI): 0.37, 0.76; VE = 47%), 0.45 (95% CI: 0.30

148 difference (MD) = 0.59 units, 95% confidence interval (CI): 0.39, 0.80), lower physical activity (MD

149 risk (odds ratio (OR) = 0.85, 95% confidence interval (CI): 0.60, 1.21).

150 lative UFP exposure was 1.04 [95% confidence interval (CI): 1.02, 1.06].

151 utrition, respectively: 2.02 [95% confidence interval (CI): 1.65 to 2.49] and 3.65 [95% CI: 2.41 to 5

152 overall incidence rates 12.5 [95% confidence interval (CI): 11.2, 14.1] and 871.1 [95% CI: 852.3, 890

153 ars were associated with 22% (95% confidence interval (CI): 14, 30), 25% (95% CI: 17, 33), and 32% (9

154 Odds ratios (OR) with 95% confidence intervals (CI) for sarcopenia were higher for men 2.82 (

155 Seroprevalence 95% confidence intervals (CI) were adjusted for assay sensitivity and s

156 sts per patient were US $847 (95% confidence interval [CI] $776-927) for FLU+5FC, and US $628 (95% CI

157 ean difference [SMD] = -0.82, 95% confidence interval [CI] -1.02 to -0.63) and active control (k-9; n

158 se changes led to a -96.1 ml (95% confidence interval [CI] -144.2 to -48.0) reduction in volume and -

159 rate = 0.28/person-year [PY], 95% confidence interval [CI] 0.22-0.35/PY).

160 l cancer incidence was 0.55% (95% confidence interval [CI] 0.40-0.75) with low-performing colonoscopi

161 rd ratio [HR] per year 0.976; 95% confidence interval [CI] 0.959-0.993).

162 re heavier at birth (58.20 g, 95% confidence interval [CI] 10.10-106.31, p = 0.02) with increased ris

163 djusted odds ratio [OR] 3.81, 95% confidence interval [CI] 2.49 to 5.86) and added a significant emot

164 g women (20-24 years), 31.7% (95% confidence interval [CI] 29.5-34.1), of whom were displaced at leas

165 = .004, odds ratio [OR] 31.3, 95% confidence interval [CI] 3.0 to 329) and cumulative RFI volatility

166 lanoma (odds ratio [OR] 5.01; 95% Confidence Interval [CI] 3.50-7.61) and kidney cancer (OR 2.50; 95%

167 ncentrations were 86% higher (95% confidence interval [CI] 42% to 143%, P < 0.001) at 2 d posttreatme

168 y for buccal samples was 51% (95% Confidence Interval [CI] 42-60%).

169 after IE diagnosis (HR 57.20, 95% confidence interval [CI] 45.58-71.78; P < .0001) and a moderately e

170 gression-free survival (PFS) (95% confidence interval [CI] 5-29, 49-69 versus 70-82 months, chi2 p =

171 , CrAgSQ was 93.0% sensitive (95% confidence interval [CI] 80.9% to 98.5%) and 93.8% specific (95% CI

172 ted ACPR at Day 42 was 96.1% (95% confidence interval [CI] 91.4-98.2; Kaplan-Meier).

173 r for African-American (0.67; 95% confidence interval [CI] = 0.58 to 0.78) and Hispanic or Latino (0.

174 erol (odds ratio [OR] = 0.92; 95% confidence interval [CI] = 0.85-0.99; p = 0.03) and LDL cholesterol

175 s (relative risk [RR] = 3.49, 95% confidence interval [CI] = 1.10-11.1, p = 0.03 and RR = 3.28, 95% C

176 esions contain 64% more iron (95% confidence interval [CI] = 17-127%, p = 0.004) than immunopattern I

177 WHR there was a 75% increase (95% confidence interval [CI] = 44-113%) in risk for large artery ischem

178 m 0.00 after 5 years to 0.22 (95% confidence interval [CI], -0.01 to 0.67) after 30 years.

179 ME from RVO, -0.56 (774 eyes; 95% confidence interval [CI], -0.61 to -0.51; P < 0.001); DME, -0.50 (9

180 rence, 0.7 percentage points; 95% confidence interval [CI], -0.9 to 2.4) - a result that satisfied th

181 roup was 2 percentage points (95% confidence interval [CI], -18 to 27) for the 20-mg dose, -25 percen

182 vel was a reduction of 39.7% (95% confidence interval [CI], -43.7 to -35.7) in the inclisiran group a

183 d saliva specimens was -3.61 (95% confidence interval [CI], -5.78 to -1.44; P = 0.002).

184 an VA change of +1.5 letters (95% confidence interval [CI], 0-3.1 letters) in the ranibizumab group a

185 ld region, from 2.6% in Asia (95% confidence interval [CI], 0-5.9) to 10.5% in Australia (95% CI, 2.8

186 ain was 0.49 events/eye-year (95% confidence interval [CI], 0.26-0.86 events/eye-year), whereas the r

187 ine to month 24 was +0.36 mm (95% confidence interval [CI], 0.27-0.45 mm) for ranibizumab and +0.28 m

188 tion hazard ratio [sHR] 0.74; 95% confidence interval [CI], 0.40-1.34; P = 0.38) and death (sHR 0.68;

189 on-years; hazard ratio, 0.69; 95% confidence interval [CI], 0.57 to 0.83; P<0.001).

190 ot statistically significant (95% confidence interval [CI], 0.57-3.06; P = 0.51).

191 e showed a myopia OR of 0.65 (95% confidence interval [CI], 0.63-0.67; P < 10(-205)) and 0.52 (95% CI

192 ograms per milliliter of PSA; 95% confidence interval [CI], 0.8, 0.9; P < .001).

193 cting (odds ratio [OR], 0.95; 95% confidence interval [CI], 0.92-0.99) and sharing (OR, 0.87; 95% CI,

194 DFS (OS: hazard ratio [HR], 0.98; confidence interval [CI], 0.97-1.00; P = 0.013; DFS: HR, 0.99; CI,

195 LT (hazard ratio [HR], 1.04; 95% confidence interval [CI], 1.01-1.07), male gender (HR, 2.48; 95% CI

196 tion (odds ratio [OR], 3.729; 95% confidence interval [CI], 1.099-12.649; P = 0.035).

197 least squares means of +1.1 (95% confidence interval [CI], 1.0;1.3), -1.3 (95%CI, -1.5;-1.0), and -3

198 phy (hazard ratio [HR], 1.70; 95% confidence interval [CI], 1.17-2.49; P = 0.006).

199 usted odds ratio [aOR], 1.75; 95% confidence interval [CI], 1.18, 2.60, P = .01), AA identity (aOR, 1

200 usted odds ratio [aOR], 1.50; 95% confidence interval [CI], 1.19-1.88), preterm premature rupture of

201 nt-days; relative risk, 1.53; 95% confidence interval [CI], 1.37 to 1.72; P<0.001).

202 ing IOP increase of 4.3 mmHg (95% confidence interval [CI], 1.4-7.3; P = 0.005) and mean increase in

203 ity (hazard ratio [HR], 1.90; 95% confidence interval [CI], 1.60-2.25; P = 5.88 x 10(-13)).

204 e RNFL thickness was 2.5 mum (95% confidence interval [CI], 1.8-3.1 mum), 2.8 mum (95% CI, 2.3-3.3 mu

205 scular (hazard ratio, 11.036; 95% confidence interval [CI], 1.807-67.393) and total (hazard ratio, 11

206 772 per 100 000 person-years (95% confidence interval [CI], 1754-1789) and 303 per 100 000 person-yea

207 nts (upper boundary of the 98.75% confidence interval [CI], 3.3), and that between the 20-mg and 5-mg

208 C virus infection (OR, 15.84; 95% confidence interval [CI], 4.06-61.87; P < 0.001) was the most signi

209 estimated 622,390 infections (95% confidence interval [CI], 579,125 to 665,655) among hospitalized pa

210 alidation cohorts were 83.5% (95% confidence interval [CI], 75.4-90.7%) and 91.9% (95% CI, 88.7-94.7%

211 Overall survival was 83.3% (95% confidence interval [CI], 76.2-88.4) at 1 year posttransplantation

212 and urine samples were 96.6% (95% confidence interval [CI], 88.5 to 99.1%) and 86.4% (95% CI, 75.5 to

213 cline-azithromycin was 95.4% (95% confidence interval [CI], 89.7-98.0) and doxycycline-moxifloxacin w

214 intervals (-61.77 milliseconds; 95% credible interval [CI]: -80.71 to -42.83) and increased sensitivi

215 meta-analyses and were 0.32% (95% confidence interval [CI]: 0.26% to 0.39% [corresponding to 1:313])

216 ion (hazard ratio [HR]: 0.76; 95% confidence interval [CI]: 0.62 to 0.94, and HR: 0.74; 95% CI: 0.58

217 e image-based model was 0.73 (95% confidence interval [CI]: 0.71, 0.74).

218 sted odds ratio [AOR] = 1.00, 95% confidence interval [CI]: 0.77-1.30, p = 0.973; women's UBL arm AOR

219 acteristic curve [AUC], 0.97; 95% confidence interval [CI]: 0.94, 1.00) and excellent interobserver r

220 ths; hazard ratio [HR], 1.87; 95% confidence interval [CI]: 1.01, 3.5; P = .04) and advanced stage PD

221 oup (hazard ratio [HR]: 1.41; 95% confidence interval [CI]: 1.04 to 1.90).

222 nance (odds ratio [OR]: 1.26; 95% confidence interval [CI]: 1.12-1.41; Q < 0.001), and greater superi

223 thy (relative risk [RR]: 1.7; 95% confidence interval [CI]: 1.2, 2.4; P = .002) and osseous metastase

224 elivery (<37 weeks) was 2.47 (95% confidence interval [CI]: 2.16 to 2.82), and further stratified was

225 s were as follows: HF: 3.18% (95% confidence interval [CI]: 2.83% to 3.57%) for sarcoidosis patients

226 in the BEV group (3.7 months; 95% confidence interval [CI]: 3.0, 4.2) compared with the non-BEV group

227 response of mOPV2 was 53.6% (95% confidence interval [CI]: 44.9%-62.1%) and 60.6% (95% CI: 52.2%-68.

228 ix metalloproteinase 1 by 8% (95% confidence interval [CI]: 6% to 10%; p < 0.001), soluble ST2 by 4%

229 rming (baseline) SSD was 81% (95% confidence interval [CI]: 80%, 82%; 190 of 234) and PPV was 36% (95

230 ture of this model was 93.7% (95% confidence interval [CI]: 90.8%, 96.5%), with a sensitivity of 93.2

231 th 98% accuracy (202 of 207) (95% confidence interval [CI]: 95%, 99%).

232 e CAD: for the PTP model, 72 (95% confidence intervals [CI]: 71 to 74); for the RF-CL model, 75 (95%

233 4.7% [odds ratio {OR} = 5.05; 95% confidence interval {CI} = 3.01 to 8.46]; for males, 16.5% versus 9

234 azobactam (difference, -5.3% [95% confidence interval {CI}, -11.9% to 1.2%]), and favorable clinical

235 bundance (4-month mean, 0.71 [95% confidence interval {CI}, .2-1.2] and 6-month mean, 0.85 [95% CI, .

236 mab (hazard ratio [HR], 0.96 [95% confidence interval {CI}, 0.74-1.25]; HR, 1.04 [95% CI, 0.78-1.38];

237 usted odds ratio [aOR], 6.08 [95% confidence interval {CI}, 1.27-29.18], P = .02) and with positive c

238 riable odds ratio [mOR], 2.9 [95% confidence interval {CI}, 1.3-6.4]; P = .008), African origin (mOR,

239 fold higher (risk ratios, 24 [95% confidence interval {CI}, 10.8-62.3] and 6 [95% CI 1.5-24], respect

240 , 2.0 per one-grade increase [95% confidence interval {CI}: 1.6, 2.4]; P < .001), carotid injuries ve

241 es per year for Medicare: 91 [95% confidence interval {CI}: 34, 148]; commercially insured patients a

242 y discontinuation were 49.9% (95% confidence interval, CI 43.6-56.5) for pembrolizumab, 58.8% (95% CI

243 ss [mean adjusted difference (95% confidence interval, CI) -3.1 kg/m (-4.4 to -1.9) kg/m, P < 0.001]

244 cidence rate ratios (RRs) and 95% confidence intervals (CIs) using Poisson regression, controlling fo

245 standard mean differences of 95% confidence intervals (CIs) were calculated with the random-effects

246 Odds ratios (ORs) with 95% confidence intervals (CIs) were determined using logistic regressio

247 incidence ratios (SIRs) with 95% confidence intervals (CIs).

248 ary relative risks (SRRs) and 95% confidence intervals (CIs).

249 ith a higher median but overlapping credible intervals compared with some other seriously affected co

250 The corresponding 95% confidence interval coverage rate ranged from 46.4% to 69.5% under

251 model projects that 2,700,000 (95% credible interval [CrI] 2,000,000-3,600,000) and 420,000 (95% CrI

252 ates were as follows: CFR 2.4% (95% credible interval [CrI] 2.1%-2.8%), sCFR 3.7% (3.2%-4.2%), and IF

253 alivae was associated with 48% (95% credible interval [CrI], 9-69%) and 25% (95% CrI, 0.5-42%) lower

254 analyses with determination of 95% credible intervals (Crls).

255 (odds ratio or hazard ratio, 95% confidence interval), diabetes (1.9, 1.4-3.0), panniculectomy (2.6,

256 The maximum corrected QT interval during treatment was significantly longer in th

257 F1 offspring: behavioral performance [fixed-interval (FI) schedule of food reward, locomotor activit

258 nd blindness prevalence rates and confidence intervals for each survey measure and age group using th

259 mance in a standard psychophysical method (2-interval forced choice, in which the participant identif

260 pillary gel electrophoresis (SDS-CGE) in the interval from 15 to 60 degrees C using borate cross-link

261 ia disease and demographic factors on the QT interval in order to improve assessment of electrocardio

262 nformation to help annotate a set of genomic intervals in terms of transcription regulation.

263 radiation and extended radiation-to-surgery intervals increase operative difficulty and complication

264 Baseline corrected QT interval intervals did not differ between patients treat

265 ical inhibition(,) 2.5 ms) and GABA(B) (long-interval intracortical inhibition(,) 150 ms) receptor ac

266 f corticospinal excitability, GABA(A) (short-interval intracortical inhibition(,) 2.5 ms) and GABA(B)

267 15 generations, supporting at least 2-years interval is needed when the rotational use of insecticid

268 ich part of the ECG signal (e.g., T-wave, ST-interval) is significantly associated with the hypoglyce

269 DAPs are found in Layer II; their interspike intervals (ISIs) reflect DAP time-scales.

270 will be classified as complete responders if intervals less than 4 weeks are used to assess anti-VEGF

271 Further study of the need for QT interval monitoring is needed before final recommendatio

272 s eyes (38 enrolled, 189 excluded) during an interval of 5 years.

273 h in some species occurs within a very short interval of each other (sometimes hours).

274 ations in rats and within the 95% confidence interval of observed plasma silver concentrations in hea

275 cene (2.6 to 3.6 Ma) is the most recent past interval of sustained global warmth with mean global tem

276 After treatment-free intervals of >=2, >=3, >=4, >=5, and >=6 months, mean (s

277 n studies (odds ratio of 2.5, 95% confidence intervals of 1.4-4.4, P = 0.0013).

278 This was repeated five times with intervals of 3-4 days between UVR exposures.

279 y (ECS) was indeed higher during the warmest intervals of the Eocene, agreeing well with recent model

280 lts clearly illustrate that the 95% credible intervals of the proposed joint estimation method (which

281 The adjusted proportion (95% confidence interval) of LTs paid by Medicaid among restrictive vers

282 egravir (800 mg given three times at 12 week intervals or 600 mg given five times, administered at on

283 nts (64.7%) either increased their injection intervals or required no further injections, 3 maintaine

284 llennia, indicating sub-millennia recurrence intervals over this time period.

285 oot planning (SRP), per quadrant at a 1-week-interval, performed with ultrasonic and periodontal hand

286 face Doppler OCT imaging with multiple time intervals ranging from 0.25 ms to 2.0 ms at a rate of 0.

287 ed, and relative SI changes from baseline to interval scans were calculated.

288 We found PR interval shortening and prolonged QRS duration, as well

289 All dose-to-imaging intervals showed significantly higher fluorescence in th

290 r is typically abstracted from a large depth interval, such mixing is even more problematic.

291 ti-CD20 administration and in different time intervals thereafter over a period of 24 mo.

292 -42.83) and increased sensitivity of the QT interval to heart rate changes.

293 ality estimates from patients with very long intervals until antibiotics with patients with shorter i

294 he lower limit of the 2-sided 90% confidence interval was -1.724 letters, which is within the noninfe

295 of DME and visual acuity when the treatment interval was extended to 8 weeks in the 2q8 group.

296 red if the lower bound of the 95% confidence interval was greater than -12%.

297 proportion metaanalysis (with 95% confidence interval) was performed using the random-effects model.

298 duration of the action potentials and the QT interval were significantly shorter in p.P888L-SAP97 tha

299 In contrast, actuarial RFS rates for similar intervals were 79.1% (95% CI 72.5%-84.2%), 64.2% (95% CI

300 intervals (36 +/- 19% of linear slopes), PQ intervals were found to be dependent on underlying cycle